Take Solutions Launches Rs. 50 Million Innovation Fund
ECONOMY & POLICY

Take Solutions Launches Rs. 50 Million Innovation Fund

Take Solutions Limited has launched an Innovation Fund with an initial corpus of Rs. 50 million to invest in startups converging AI, deep technology and the health and wellness sector. The fund will target early and growth stage companies that leverage data, artificial intelligence and scientific innovation to transform diagnostics, delivery and health outcomes. The company said the move represents a strategic pivot towards next generation technology led business models and long term shareholder value creation.

The Innovation Fund will provide capital and strategic support including domain expertise, global networks and go to market access to accelerate commercialisation and scalability. The fund will prioritise investments in AI led diagnostics, longevity and bio convergence, digital health platforms and technology infrastructure that enhance efficiency and compliance. The approach is designed to reduce time to market and increase the probability of success for portfolio companies by combining capital with operational capabilities.

The company highlighted India's expanding health and wellness market projected to grow to $400 to $500 billion over the next decade, driven by rising digital adoption, healthcare awareness and increasing life expectancy. It noted chronic diseases account for nearly 60 per cent of deaths and that extending healthspan creates opportunities in predictive analytics, precision medicine and digital therapeutics. Take.Health, an AI driven platform recently launched by the company, aims to convert everyday lifestyle and medical data into personalised actionable insights for consumer and enterprise segments.

The investment thesis is anchored in the convergence of biology and technology and seeks long term, high impact outcomes while generating sustainable financial returns. The fund will leverage the company's expertise in life sciences and supply chain management, institutional partnerships across clinical and regulatory networks, and established go to market channels to support portfolio commercialisation. With disciplined deployment and execution capabilities, the company expects the initiative to strengthen its position in innovation led sectors and participate in the evolving technology driven economy.

Take Solutions Limited has launched an Innovation Fund with an initial corpus of Rs. 50 million to invest in startups converging AI, deep technology and the health and wellness sector. The fund will target early and growth stage companies that leverage data, artificial intelligence and scientific innovation to transform diagnostics, delivery and health outcomes. The company said the move represents a strategic pivot towards next generation technology led business models and long term shareholder value creation. The Innovation Fund will provide capital and strategic support including domain expertise, global networks and go to market access to accelerate commercialisation and scalability. The fund will prioritise investments in AI led diagnostics, longevity and bio convergence, digital health platforms and technology infrastructure that enhance efficiency and compliance. The approach is designed to reduce time to market and increase the probability of success for portfolio companies by combining capital with operational capabilities. The company highlighted India's expanding health and wellness market projected to grow to $400 to $500 billion over the next decade, driven by rising digital adoption, healthcare awareness and increasing life expectancy. It noted chronic diseases account for nearly 60 per cent of deaths and that extending healthspan creates opportunities in predictive analytics, precision medicine and digital therapeutics. Take.Health, an AI driven platform recently launched by the company, aims to convert everyday lifestyle and medical data into personalised actionable insights for consumer and enterprise segments. The investment thesis is anchored in the convergence of biology and technology and seeks long term, high impact outcomes while generating sustainable financial returns. The fund will leverage the company's expertise in life sciences and supply chain management, institutional partnerships across clinical and regulatory networks, and established go to market channels to support portfolio commercialisation. With disciplined deployment and execution capabilities, the company expects the initiative to strengthen its position in innovation led sectors and participate in the evolving technology driven economy.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code